SC 13G Filing

Company

Viridian Therapeutics, Inc.\DE

Filed

March 10, 2017

Accession Number

0000315066-17-002214

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →